Epstein Secrets

to David Sanger. Clapper said his office's "first key judgment in 2016" was that "the initial objective was to sow doubt, discord, and discontent." Clapper added that Russian actors "exploit and amplify the polarization and divisiveness" in the US. Opinion: Iran's Election Interference Aims Also To Dis

s are creating a "perception hack," meaning they want the "perception that they're inside the system, and sow distrust," according to David Sanger. Clapper said his office's "first key judgment in 2016" was that "the initial objective was to sow doubt, discord, and discontent." Clapper added that Russia

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AP (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

rs are creating a "perception hack," meaning they want the "perception that they're inside the system, and sow distrust," according to David Sanger. Clapper said his office's "first key judgment in 2016" was that "the initial objective was to sow doubt, discord, and discontent." Clapper added that Russi

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AE (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

rs are creating a "perception hack," meaning they want the "perception that they're inside the system, and sow distrust," according to David Sanger. Clapper said his office's "first key judgment in 2016" was that "the initial objective was to sow doubt, discord, and discontent." Clapper added that Russia

for treatments." Calling the meeting "an usual step," the AP <https://apnews.corn/article/virus-outbreak- e49203f5c55ba593ca587a56d0116b97> (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust a